References
- 1. Scott M. The pathology of cervical cancer. In: Ayhan A, Reed N, Gulterin M, Dursun P, editors. Textbook of Gynaecological Oncology. 3rd ed. Ankara, Turkey: Gunes Publishing; 2016. pp. 376-380.
- 2. American College of Obstetricians and Gynaecologists. ACOG Practice Bulletin No99: Management of abnormal cervical cytology and histology. Obstet Gynecol 2008; 112(6); 1419-1444. Reaffirmed 2010.
- 3. Martin CM, O’Leary JJ. Histology of cervical intraepithelial neoplasia and the role of biomarkers. In: Arul Kumaran S, editor. Best Practice & Research: Clinical Obstetrics & Gynaecology. 25th ed. Philadelphia, USA: Elsevier; 2011. pp. 605-615.
- 4. Abreu ALP, Souza RP, Gimenes F, et al. A review of methods for detect human papillomavirus infection. Virology Journal 2012; 9:262.10.1186/1743-422X-9-262
- 5. Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. 2008; 26:29-41.
- 6. Rosenblatt S, Wroclawski ER, Lucon AM, Pereyra EAG, editors. HPV in Clinical Practice. Sao Paulo: Atheneu; 2005.
- 7. Hwang SJ, Shroyer KR. Biomarkers of Cervical Dysplasia and Carcinoma. Journal of Oncology 2012; 2012:9.10.1155/2012/507286
- 8. Coquillard G, Palao B, Patterson BK. Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol 2011; 120(1):89-93.
- 9. Sorbye SW, Arbyn M, Fismen S, et al. HPV E6/ E7 mRNA Testing Is More Specific than Cytology in Post-Colposcopy Follow-Up of Women with Negative Cervical Biopsy. PLoS ONE 2011; 6(10):e26022.
- 10. Kraus I, Molden T, Holm R, et al. Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33 and 45 in the Majority of Cervical Carcinomas. J Clin Microbiol 2006; 44:1310–1317.
- 11. Zerat L. La nouvelle terminologie de Bethesda: quellschangements? Rev Prat Gynecol Obstet. Numero Special 2002; 3-10.
- 12. Solomon D, Davey D, Kurman R. The 2001 Bethesda System. Terminology for reporting results of cervical cytology. JAMA 2002; 287:2114-19.
- 13. Kurman RJ, Carcangin ML, Herrington CS, Young RH, editors. World Health Organization Classification of Tumors of Female Reproductive Organs. 4th ed. Lyon, France: IARC Press; 2014.
- 14. Castle PE, Dockter J, Giachetti G, et al. A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer. AACR 2007; 13:2599-2605.
- 15. Vieira L, Almeida A. The cytology and DNA detection by the Papillo Check test in the diagnosis of human papillomavirus infection. Eur J Microbiol Immunol 2013; 3(1):61-7.
- 16. Mazarico E, Gonzalez-Bosquet E. Prevalence of infection by different genotypes of human papillomavirus in women with cervical pathology. Gynecol Oncol 2012; 125(1):181-5.
- 17. Pista A, de Oliveira CF, Lopes C, et al; CLEOPATRE Portugal Study Group. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study. Int J Gynecol Cancer 2013; 23(3):500-6.10.1097/IGC.0b013e318280f26e
- 18. Bzhalava D, Eklund C, Dillner J. International standardization and classification of human papillomavirus types. Virology. 2015; 476:341-4.
- 19. Fontecha N, Basaras M, Hernaez S, et al. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker. BMC Cancer 2016; 16:852.10.1186/s12885-016-2885-x
- 20. Oliveira A, Verdasca N, Pista A. Use of the Nucli SENS Easy Q HPV assay in the management of cervical intraepithelial neoplasia. J Med Virol 2013; 85(7):1235-1241.
- 21. Cattani P, Siddu A, DÓnghia S, et al. RNA (E6 and E7) assay versus DNA (E6 and E7) assay for risk evaluation for women infected with human papillomavirus. J Clin Microbiol 2009; 2136-2141.10.1128/JCM.01733-08
- 22. Tuney I, Altay A, Ergunay K, et al. HPV types and E6/E7 mRNA expression in cervical samples from Turkish women with abnormal cytology in Ankara, Turkey. Turk J Med Sci 2017; 1508-155.
- 23. Doganov A, Kostova P, Boyanova M, et al. Application of the RNA-based HPV test in the diagnostics of cervical epithelial changes. Akush Ginekol 2012; 51(3):22-4.
- 24. Trope A, Sjoborg K, Eskild A, et al. Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia. J Clin Microbiol 2009; 47(8):2458-2464.
- 25. Spathis A, Kottaridi C, Chranioti A, et al. mRNA and DNA detection of human papillomaviruses in women of all ages attending two colposcopy clinics. PLoS One 2012; 7(11):e49205.
- 26. Salimovic-Besic I, Tomic-Cica A, Smailjic A, et al. Comparison of the detection of HPV-16, 18, 31, 33 and 45 by type-specific DNA- and E6/ E7 mRNA-based assays of HPV DNA positive women with abnormal Pap smears. J virol Methods 2013; 194(1-2):222-228.
- 27. Duvlis S, Popovska-Jankovic K, Sarafimovska- Arsova Z, et al. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women. J Med Virol 2015; 87(9):1578-1586.
- 28. Munkhdelger J, Choi Y, Lee D, et al. Comparison of the performance of the Nucli SENS Easy Q HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix. Diagnos Microbiol Inf Dis 2014; 422-427.10.1016/j.diagmicrobio.2014.04.004